Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BHAVNA SHARMA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1619921822
CMS profile
836131
Location
MADISON, AL

General Payments · PY2018–2024

$1,383.91

  • Reported across 79 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$509.78

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $509.78 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Inspire Medical Systems, Inc. $187.35 1
Novo Nordisk AS $144.85 26
Eurofins Viracor, Inc. $43.95 1
Exact Sciences Corporation $36.44 2
Respicardia, Inc. $30.85 2
Grifols USA, LLC $24.34 1
GlaxoSmithKline, LLC. $15.48 1
Acerta Pharma LLC $13.45 1
Amgen Inc. $13.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $269.22 10
PY2019 $199.40 14
PY2020 $54.50 3
PY2021 $88.52 6
PY2022 $134.04 8
PY2023 $128.45 2
PY2024 $509.78 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $13.07 02/07/2024 Food and Beverage Undisputed 01/23/2026 1117380722 CMS
AstraZeneca Pharmaceuticals LP $13.45 10/17/2024 Food and Beverage Undisputed 01/23/2026 1104231863 CMS
Eurofins Viracor, LLC $43.95 04/03/2024 Food and Beverage Undisputed 01/23/2026 1144516043 CMS
Exact Sciences Corporation $15.68 07/09/2024 Food and Beverage Undisputed 01/23/2026 1114891155 CMS
Exact Sciences Corporation $20.76 10/22/2024 Food and Beverage Undisputed 01/23/2026 1114891161 CMS
GlaxoSmithKline, LLC. $15.48 06/11/2024 Food and Beverage Undisputed 01/23/2026 1116613726 CMS
Grifols USA, LLC $24.34 05/17/2024 Food and Beverage Undisputed 01/23/2026 1124755612 CMS
Inspire Medical Systems, Inc. $187.35 09/12/2024 Food and Beverage Undisputed 01/23/2026 1148109797 CMS
Novo Nordisk Inc $4.35 01/29/2024 Food and Beverage Undisputed 01/23/2026 1097442765 CMS
Novo Nordisk Inc $5.92 01/29/2024 Food and Beverage Undisputed 01/23/2026 1097555338 CMS
Novo Nordisk Inc $5.39 02/12/2024 Food and Beverage Undisputed 01/23/2026 1096887112 CMS
Novo Nordisk Inc $1.66 02/12/2024 Food and Beverage Undisputed 01/23/2026 1097071289 CMS
Novo Nordisk Inc $6.12 02/27/2024 Food and Beverage Undisputed 01/23/2026 1096824432 CMS
Novo Nordisk Inc $5.14 03/04/2024 Food and Beverage Undisputed 01/23/2026 1096966953 CMS
Novo Nordisk Inc $3.25 04/01/2024 Food and Beverage Undisputed 01/23/2026 1096612864 CMS
Novo Nordisk Inc $6.03 04/03/2024 Food and Beverage Undisputed 01/23/2026 1097268706 CMS
Novo Nordisk Inc $5.11 04/10/2024 Food and Beverage Undisputed 01/23/2026 1097132161 CMS
Novo Nordisk Inc $5.66 04/19/2024 Food and Beverage Undisputed 01/23/2026 1097719793 CMS
Novo Nordisk Inc $7.25 04/30/2024 Food and Beverage Undisputed 01/23/2026 1096831263 CMS
Novo Nordisk Inc $2.85 05/02/2024 Food and Beverage Undisputed 01/23/2026 1097835113 CMS
Novo Nordisk Inc $6.03 05/08/2024 Food and Beverage Undisputed 01/23/2026 1097052947 CMS
Novo Nordisk Inc $6.16 05/15/2024 Food and Beverage Undisputed 01/23/2026 1097415649 CMS
Novo Nordisk Inc $2.89 05/16/2024 Food and Beverage Undisputed 01/23/2026 1097508433 CMS
Novo Nordisk Inc $6.73 05/29/2024 Food and Beverage Undisputed 01/23/2026 1097561983 CMS
Novo Nordisk Inc $6.13 06/19/2024 Food and Beverage Undisputed 01/23/2026 1097018266 CMS
Novo Nordisk Inc $6.11 07/18/2024 Food and Beverage Undisputed 01/23/2026 1096917884 CMS
Novo Nordisk Inc $4.25 07/22/2024 Food and Beverage Undisputed 01/23/2026 1096678006 CMS
Novo Nordisk Inc $22.45 07/30/2024 Food and Beverage Undisputed 01/23/2026 1097037938 CMS
Novo Nordisk Inc $2.85 08/06/2024 Food and Beverage Undisputed 01/23/2026 1096695915 CMS
Novo Nordisk Inc $6.07 08/22/2024 Food and Beverage Undisputed 01/23/2026 1096639291 CMS
Novo Nordisk Inc $2.29 09/04/2024 Food and Beverage Undisputed 01/23/2026 1097494409 CMS
Novo Nordisk Inc $2.10 09/10/2024 Food and Beverage Undisputed 01/23/2026 1096870240 CMS
Novo Nordisk Inc $6.72 09/25/2024 Food and Beverage Undisputed 01/23/2026 1097156507 CMS
Novo Nordisk Inc $5.34 10/23/2024 Food and Beverage Undisputed 01/23/2026 1096930114 CMS
ZOLL Respicardia, Inc. $17.72 02/20/2024 Food and Beverage Undisputed 01/23/2026 1146936988 CMS
ZOLL Respicardia, Inc. $13.13 09/11/2024 Food and Beverage Undisputed 01/23/2026 1146936990 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.